Two Schemes Response in Multiple Myeloma
Retrospective study based on medical records of patients with multiple myeloma, eligible for stem cell transplantation, who received, first-line, the VTD or TD combination.
- EligibilityCriteria: Inclusion Criteria:  clinical records of patients who were considered eligible for transplant due to their functional status and who were given some treatment strategy comprising a combination of drugs.  Exclusion Criteria:  Incomplete clinical records Clinical records of patients who abandoned treatment or could not continue with the treatment due to economic or distance issues Clinical records of patients who presented severe sepsis before the beginning of either treatment - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - MaximumAge: 90 Years - StdAgeList: Adult, Older Adult - StudyPopulation: Clinical records of patients diagnosed with multiple myeloma treated at Hospital General de México between 2020 and 2023. - SamplingMethod: Non-Probability Sample